Natera (NTRA) to report earnings tomorrow: here is what to expect

What happened

Natera, a genetic testing company, is scheduled to report earnings Thursday after the market closes. Analysts expect revenue to grow 19.8% year over year this quarter, slower than the 34.7% growth recorded in the same quarter last year. Estimates were generally unchanged over the last 30 days.

Confirmed

Global impact / market context

The report will show whether Natera’s sales growth is slowing as expected and whether its results meet analysts’ forecasts. A stronger or weaker result could change expectations for future revenue and influence how investors value the company’s shares, though the article gives no forecast for the share-price response.

Analyst inference

Last quarter, Natera beat revenue and earnings-per-share forecasts, and its full-year revenue guidance was above analysts’ expectations. The article also notes that peer companies Regeneron and Incyte exceeded estimates, but their reported growth rates differ and do not establish Natera’s likely result.

Confirmed

What to watch

1. Compare Natera’s reported revenue growth with the 19.8% year-over-year expectation and the 34.7% pace in the same quarter last year. Confirmed
2. Check whether Natera reports earnings per share above or below analysts’ estimates; earnings per share is profit attributed to each share. Proposed
3. Watch for any change to full-year revenue guidance, because revised expectations could alter investors’ view of Natera’s future sales growth. Analyst inference

Evidence

• stockstory.org